Signal active
Investment Firm
Overview
Flagship Pioneering conceives, creates, resources, and grows first-in-category ventures to transform human health and sustainability. The company accelerates Flagship Pioneering’s advances in biology, engineering, medicine, energy, and beyond. The firm harnesses science and entrepreneurialism to envision alternative futures, beginning with seemingly unreasonable propositions and navigating to transformational outcomes through an evolutionary methodology.
Flagship Pioneering combines innovative capacity, entrepreneurial leadership, and professional capital management in a single enterprise that systematically produces first-in-category companies.
Highlights
2000
Venture Capital
5001-10000
274
96
66
Early Stage Venture, Late Stage Venture, Seed, Private Equity
Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
Flagship Pioneering, established in 2000 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Seed, Private Equity investments across Information Services, Marketing, Analytics, Lead Generation, Financial Services, Venture Capital, Finance, Security, Software, Cyber Security. The organization boasts a portfolio of 274 investments, with an average round size of $61.2M and 66 successful exits. Their recent investments include ZoomInfo, Commonwealth Capital Ventures, Venrock, Vulcan Capital, Ascent Venture Partners. The highest investment round they participated in was $853.0B. Among their most notable exits are ZoomInfo and Commonwealth Capital Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
274
45
96
66
Investments
274
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Nov 21, 2023 | Quotient Therapeutics | Biotechnology | 50.0M |
Dec 19, 2023 | Syros Pharmaceuticals | Biotechnology | 45.0M |
Jan 30, 2024 | - | - | 103.0M |
May 07, 2024 | Prologue Medicines | Health Care | 50.0M |
Exits
66
Funding Timeline
274
0
9
Funding Rounds
274
Flagship Pioneering has raised 274 rounds. Their latest funding was raised on May 07, 2024 from a Series A - Prologue Medicines round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Nov 21, 2023 | Seed Round - Quotient Therapeutics | - | 50.0M | - |
Dec 19, 2023 | Post-IPO Equity - Syros Pharmaceuticals | - | 45.0M | - |
Jan 30, 2024 | Series F - Inari | - | 103.0M | - |
May 07, 2024 | Series A - Prologue Medicines | - | 50.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.